期刊文献+

过敏性紫癜病儿血清LXA_4、LTB_4、IL-5与CRP变化及意义 被引量:7

CHANGES IN SERUM LEVELS OF LIPOXIN A_4, TB_4, IL-5 AND CRP IN CHILDREN WITH HENOCH-SCHONLEIN PURPURA AND THE CORRESPONDING SIGNIFICANCE
下载PDF
导出
摘要 目的测定过敏性紫癜病儿在不同发病阶段的血清脂氧素A4(LXA4)、白三烯B4(LTB4)、白介素-5(IL-5)以及C反应蛋白(CRP)变化,以探讨LXA4、LTB4、IL-5和CRP在儿童过敏性紫癜发病机制中的作用。方法采集31例过敏性紫癜病儿急性期和恢复早期血清,以及27例正常儿童(正常组)血清,用酶联免疫吸附试验检测血清中LXA4、LTB4、IL-5和CRP含量。结果过敏性紫癜病儿急性期和恢复早期血清LXA4、LTB4、IL-5和CRP水平均显著高于正常组(F=85.15~345.81,q=7.60~36.98,P<0.01)。过敏性紫癜病儿急性期血清LTB4、IL-5和CRP水平均显著高于恢复早期(q=10.68~20.82,P<0.01);而急性期血清LXA4水平显著低于恢复早期(q=14.72,P<0.01)。结论LTB4和IL-5可能参与过敏性紫癜的病变过程,而LXA4具有抗炎作用。 Objective To investigate the serum levels of lipoxin A4 (LXA4), leukotriene B4 ( LTB4 ), interleukin-5 (IL-5) and C-reactive protein (CRP) in children with Henoch-Schonlein purpura (HSP) in different phases and to explore the role of LXA4, LTB4, IL5 and CRP in the pathogenesis of the disease. Methods The serum LXA4, LTB4, IL-5 and CRP in 27 normal children and 31 HSP in cute phase and early recovery phase were detected by ELISA, respectively. Results The serum LXA4, LTB4, IL-5 and CRP in the patients in acute and early recovery phase were significantly higher than that in normal group (F= 85. 15-345.81,q=7.60-36.98,P〈0.01), LTB4, IL-5 and CRP in acute phase were significantly higher than that in early recovery phase (q=10.68-20.82,P〈0.01). However, the serum level of LXA4 in the patients in acute phase was significantly lower than that in the early recovery phase (q=14.72,P〈0.01). Conclusion LTB4 and IL-5 may be involved in the pathological changes of HSP and LXA4 possesses an anti-inflammatory action.
出处 《齐鲁医学杂志》 2007年第4期317-319,共3页 Medical Journal of Qilu
关键词 紫癜 过敏性 脂氧素 白三烯B4 白细胞介素5 C反应蛋白质 儿童 purpura,Henoch-Schonlein lipoxin leukotriene B4 interleukin-5, C-reactive protein children
  • 相关文献

参考文献6

二级参考文献56

  • 1吴升华,陆超,董玲,姜新猷.脂氧素A4通过上调Smac表达诱导肾间质成纤维细胞凋亡[J].中华肾脏病杂志,2004,20(5):339-342. 被引量:7
  • 2[1]Iversen L, Fogh K, Ziboh VA, et al. Leukotriene B4 formation during human neutrophil keratinocyte interactions: evidence for transformation of leukotriene A4 by putative keratinocyte leukotriene A4 hydrolase[J]. J Invest Dermatol, 1993, 100(3): 293-298. 被引量:1
  • 3[2]James JM, Kagey-Sobotka A, Sampson HA. Patients with severe atopic dermatitis have activated circulating basophils[J]. J Allergy Clin Immunol, 1993, 91(6): 1155-1162. 被引量:1
  • 4[3]Shichijo M, Ebisawa M, Miura K, et al. Relationship between histamine release and leukotrienes production from human basophils derived from atopic dermatitis donors[J]. Int Arch Allergy Immunol, 1995, 107(4): 587-591. 被引量:1
  • 5[4]Fogh K, Herlin T, Kragballe K. Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations [J]. J Allergy Clin Immunol, 1989, 83(2 Pt 1): 450-455. 被引量:1
  • 6[5]Ruzicka T, Simmet T, Peskar BA, et al. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis[J]. J Invest Dermatol, 1986, 86(2): 105-108. 被引量:1
  • 7[6]Koro O, Furutani K, Hide M, et al. Chemical mediators in atopic dermatitis: involvement of leukotriene B4 released by a type I allergic reaction in the pathogenesis of atopic dermatitis[J]. J Allergy Clin Immunol, 1999, 103(4): 663-670. 被引量:1
  • 8[7]Sansom JE, Taylor GW, Dollery CT, et al. Urinary leukotriene E4 levels in patients with atopic dermatitis [J]. Br J Dermatol,1997, 136(5): 790-791. 被引量:1
  • 9[8]Adamek-Guzik T, Guzik TJ, Czerniawska-Mysik G, et al. Urinary leukotriene levels are increased during exacerbation of atopic eczema/dermtitis syndrome. Relation to clinical status[J]. Allergy,2002, 57(8): 732-736. 被引量:1
  • 10[9]Capella GL, Grigerio E, Altomare G. A randomized trial of leukotriene receptor antagonist montelukast in moderate -to -severe atopic dermtitis of adults[J].Eur J Dermatol, 2001,11(3): 209-213. 被引量:1

共引文献66

同被引文献62

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部